Study of Safety of RVL-1201 in Treatment of Blepharoptosis
Clinical trial NCT03536949 · COMPLETED
Trial details
- NCT number
- NCT03536949
- Sponsor
- RVL Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-20
- Primary completion
- 2019-03-14
- Enrollment
- 234
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.